Zur Rose grows by 23.6% and revamps DocMorris
Premium
25 January 2021
Switzerland’s Zur Rose Group reported sales up by 23.6% in local currencies in the fourth quarter of 2020, as it sought to transform itself from a pure mail-order pharmacy into a European healthcare ecosystem using DocMorris as an umbrella brand.